RobertEGersztenMD
Cardiology • Boston, MACardiovascular Disease Genetics
Chief of Cardiovascular Medicine, Beth Israel Deaconess Medical Center Herman Dana Professor of Medicine, Harvard Medical School
Dr. Gerszten is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
185 Pilgrim Road
Farr Building, Baker 4
Boston, MA 02215Phone+1 617-667-8800Fax+1 617-632-7620
Education & Training
Massachusetts General HospitalFellowship, Cardiovascular Disease, 1996
University of Pennsylvania Health SystemResidency, Internal Medicine, 1989 - 1993
Johns Hopkins University School of MedicineClass of 1989
Certifications & Licensure
CA State Medical License 1991 - Present
MA State Medical License 1993 - 2026
PA State Medical License 1990 - 1991- American Board of Internal Medicine Cardiovascular Disease
Awards, Honors, & Recognition
- Elected Member The American Society for Clinical Investigation, 2006
Publications & Presentations
PubMed
- 167 citationsA potential therapeutic role for angiotensin-converting enzyme 2 in human pulmonary arterial hypertension.Anna R. Hemnes, Anandharajan Rathinasabapathy, Eric A. Austin, Evan L. Brittain, Erica J. Carrier
The European Respiratory Journal. 2018-06-01 - 91 citationsMolecular Transducers of Physical Activity Consortium (MoTrPAC): Mapping the Dynamic Responses to Exercise.James A. Sanford, Christopher D. Nogiec, Malene E. Lindholm, Joshua N. Adkins, David Amar
Cell. 2020-06-25 - 236 citationsA Genome-wide Association Study of the Human Metabolome in a Community-Based CohortEugene P. Rhee, Jennifer E. Ho, Ming-Huei Chen, Dongxiao Shen, Susan Cheng
Cell Metabolism. 2013-07-02
Press Mentions
Scientists Find Predictors of Heart Disease Among Black Americans That Are Shared Across EthnicitiesJanuary 21st, 2022- New Research Suggests a Blood Test Can Help Direct Our WorkoutsJuly 15th, 2021
- A Blood Test Could Reveal Which Type of Exercise Is Most Effective for YouJune 12th, 2021
- Join now to see all
Grant Support
- Metabolomic Biomarkers Of Early Myocardial InjuryNational Heart, Lung, And Blood Institute2010–2012
- Clinical Characterization Of The Apol1-Associated PhenotypeNational Institute Of Diabetes And Digestive And Kidney Diseases2011
- Integrating Lipid Genotyes And Phenotypes In IPS Derived Hepatocytes/AdipocytesNational Heart, Lung, And Blood Institute2011
- Discovery &Application Of Proteomics-Based Biomarkers Of Early Myocardial InjuryNational Heart, Lung, And Blood Institute2009–2011
- Metabolomic Predictors Of Insulin Resistance And DiabetesNational Institute Of Diabetes And Digestive And Kidney Diseases2008–2011
- Role Of ILK In Leukocyte RecruitmentNational Heart, Lung, And Blood Institute2005–2009
- Novel Markers: Pathways, Prognosis, &PharmacoproteomicsNational Heart, Lung, And Blood Institute2005–2008
- Patients Undergoing Alcohol Septal Ablation For Hypertrophic CardiomyopathyNational Heart, Lung, And Blood Institute2005
- Biomarkers In "Normal" Myocardial Ischemia And InfarctionNational Heart, Lung, And Blood Institute2005
- Clinical Evaluation Of Novel Markers Of MINational Heart, Lung, And Blood Institute2002–2005
- Chemokine Signal In Monocyte RecruitmentNational Heart, Lung, And Blood Institute2001–2003
- Chemokine Signaling In Monocyte Recruitment In VivoNational Heart, Lung, And Blood Institute2001–2002
- Molecular Signals In Monocyte RecruitmentNational Heart, Lung, And Blood Institute1996–2000
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
